Literature DB >> 1997396

Oligodendrocyte-macrophage interactions in vitro triggered by specific antibodies.

N J Scolding1, D A Compston.   

Abstract

The final pathway of myelin destruction in immune-mediated demyelination is phagocytosis by macrophages. As part of a systematic study of mechanisms of myelin-oligodendrocyte injury, we have used an in vitro approach to investigate interactions between rat oligodendrocytes and macrophages in order to identify the conditions under which macrophages adhere to and damage oligodendrocytes. No adherence was seen when macrophages alone were co-cultured with homologous oligodendrocytes. However, macrophage attachment to oligodendrocytes was triggered not only by antibody to the major cell-surface component galactocerebroside, but also by antibody to the quantitatively minor antigen, myelin-oligodendrocyte glycoprotein; immunocytochemical observations suggested that phagocytosis of myelin antigen also occurred. No such changes were seen in the presence of an irrelevant (anti-progesterone) antibody, or in the presence of activated complement. These results emphasize that a variety of antibodies, including those to minor myelin-oligodendrocyte antigens, may play a significant role in the development of demyelinated lesions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1997396      PMCID: PMC1384348     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  18 in total

1.  Immunoregulatory molecules and IL 2 receptors identified in multiple sclerosis brain.

Authors:  F M Hofman; R I von Hanwehr; C A Dinarello; S B Mizel; D Hinton; J E Merrill
Journal:  J Immunol       Date:  1986-05-01       Impact factor: 5.422

2.  A novel myelin-associated glycoprotein defined by a mouse monoclonal antibody.

Authors:  C Linnington; M Webb; P L Woodhams
Journal:  J Neuroimmunol       Date:  1984 Sep-Oct       Impact factor: 3.478

3.  The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3.

Authors:  C D Dijkstra; E A Döpp; P Joling; G Kraal
Journal:  Immunology       Date:  1985-03       Impact factor: 7.397

4.  Continual breakdown and regeneration of myelin in progressive multiple sclerosis plaques.

Authors:  J W Prineas; E E Kwon; E S Cho; L R Sharer
Journal:  Ann N Y Acad Sci       Date:  1984       Impact factor: 5.691

5.  Opsonization with antimyelin antibody increases the uptake and intracellular metabolism of myelin in inflammatory macrophages.

Authors:  J Trotter; L J DeJong; M E Smith
Journal:  J Neurochem       Date:  1986-09       Impact factor: 5.372

6.  Macrophage heterogeneity in the rat as delineated by two monoclonal antibodies MRC OX-41 and MRC OX-42, the latter recognizing complement receptor type 3.

Authors:  A P Robinson; T M White; D W Mason
Journal:  Immunology       Date:  1986-02       Impact factor: 7.397

7.  Normal rat serum cytotoxicity against syngeneic oligodendrocytes. Complement activation and attack in the absence of anti-myelin antibodies.

Authors:  N J Scolding; B P Morgan; A Houston; A K Campbell; C Linington; D A Compston
Journal:  J Neurol Sci       Date:  1989-02       Impact factor: 3.181

8.  The role of phospholipases from inflammatory macrophages in demyelination.

Authors:  J Trotter; M E Smith
Journal:  Neurochem Res       Date:  1986-03       Impact factor: 3.996

9.  Multiple sclerosis: capping of surface immunoglobulin G on macrophages engaged in myelin breakdown.

Authors:  J W Prineas; J S Graham
Journal:  Ann Neurol       Date:  1981-08       Impact factor: 10.422

10.  Immunocytochemical localization of basic protein in major dense line regions of central and peripheral myelin.

Authors:  F X Omlin; H D Webster; C G Palkovits; S R Cohen
Journal:  J Cell Biol       Date:  1982-10       Impact factor: 10.539

View more
  12 in total

1.  Imaging Ca2+ changes in individual oligodendrocytes attacked by T-cell perforin.

Authors:  J Jones; S Frith; S Piddlesden; B P Morgan; D A Compston; A K Campbell; M B Hallett
Journal:  Immunology       Date:  1991-12       Impact factor: 7.397

2.  Limiting and repairing the damage in multiple sclerosis.

Authors:  A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-11       Impact factor: 10.154

Review 3.  The role of macrophage subpopulations in autoimmune disease of the central nervous system.

Authors:  J Bauer; S R Ruuls; I Huitinga; C D Dijkstra
Journal:  Histochem J       Date:  1996-02

4.  Susceptibility to multiple sclerosis and the immunoglobulin heavy chain variable region.

Authors:  N W Wood; S J Sawcer; H F Kellar-Wood; P Holmans; D Clayton; N Robertson; D A Compston
Journal:  J Neurol       Date:  1995-10       Impact factor: 4.849

Review 5.  Risk Factors from Pregnancy to Adulthood in Multiple Sclerosis Outcome.

Authors:  Enrique González-Madrid; Ma Andreina Rangel-Ramírez; María José Mendoza-León; Oscar Álvarez-Mardones; Pablo A González; Alexis M Kalergis; Ma Cecilia Opazo; Claudia A Riedel
Journal:  Int J Mol Sci       Date:  2022-06-25       Impact factor: 6.208

Review 6.  Lame ducks or fierce creatures? The role of oligodendrocytes in multiple sclerosis.

Authors:  T Zeis; N Schaeren-Wiemers
Journal:  J Mol Neurosci       Date:  2008-02-16       Impact factor: 3.444

7.  The effect of methylprednisolone on monocyte eicosanoid production in patients with multiple sclerosis.

Authors:  P F Kirk; J D Williams; M M Petersen; D A Compston
Journal:  J Neurol       Date:  1994-06       Impact factor: 4.849

8.  IL-1, IL-2 and IFN-gamma production by Theiler's virus-induced encephalomyelitic SJL/J mice.

Authors:  N Rubio; C Torres
Journal:  Immunology       Date:  1991-10       Impact factor: 7.397

Review 9.  Adaptive immune responses in CNS autoimmune disease: mechanisms and therapeutic opportunities.

Authors:  Rhoanne C McPherson; Stephen M Anderton
Journal:  J Neuroimmune Pharmacol       Date:  2013-04-09       Impact factor: 4.147

10.  Immunological mechanisms of demyelination.

Authors:  R A Hughes
Journal:  J R Soc Med       Date:  1992-01       Impact factor: 18.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.